FDA Commissioner Makary testifies on FY 2026 discretionary budget before Senate Appropriations subcommittee
Food and Drug Administration Commissioner Marty Makary testified May 22 before the Senate Appropriations Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies on the discretionary budget proposal for fiscal year 2026. The proposal includes $93.8 billion for the Department of Health and Human Services, which oversees the FDA. The allocation is a 26.2% reduction from the FY 2025 enacted level.
AHA members received a Special Bulletin May 2 with more information on the discretionary budget proposals that could impact hospitals and health systems.
Related News Articles
Headline
The Centers for Medicare & Medicaid Services estimated national health spending grew 8.2% in 2024 and expects a 7.1% increase in 2025, the agency reported…
Headline
Secretary of Health and Human Services Robert F. Kennedy Jr. today appeared before the House Energy and Commerce Subcommittee on Health for a hearing to…
Headline
The Senate Health, Education, Labor, and Pensions Committee today released its text for the budget reconciliation bill. The text includes one health care…
Headline
The Trump administration May 30 released supplemental documents on its fiscal year 2026 discretionary budget request to Congress. The proposal includes $94.7…
Headline
Secretary of Health and Human Services Robert F. Kennedy Jr. May 20 appeared before the Senate Appropriations Committee for a hearing to testify on the…
Headline
The AHA April 30 released a report highlighting how hospitals and health systems continue to experience significant financial headwinds that can challenge…